Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
The gentle tapping sound reminds me of a woodpecker–rhythmic and purposeful. I'm observing a transcranial magnetic stimulation (TMS) session, watching as magnetic pulses target specific regions of the ...
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...
TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...
An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with treatment-resistant depression. Researchers tracked changes in a critical brain receptor ...
A clinical trial is underway to test a drug-free stimulation therapy to see if it can relieve symptoms of postpartum depression.
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) highlighted progress across its clinical pipeline and reaffirmed its financial outlook during its 2026 Virtual Investor Day, outlining plans to advance its ...
Believe in WE, and together we will work to help you realize a better quality of life and improved mental wellness for anyone seeking relief from depression, anxiety, and bipolar and other mood ...
Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, today announced the expansion of its depression treatment ...
Insurance supported, clinically based treatment for drug and alcohol addiction. We offer access to drug & alcohol treatment programs that offer medical and psychological care, individual and group ...